Clinical Trials Browser

OTHER × eribulin × Tumor-Agnostic × Clear all

NCT02640508 2024-05-09

Eribulin and Lenvatinib in Advanced Solid Tumors

Phase 2 Completed

29 enrolled 13 charts

Neoplasms